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C4
TREATMENT FOR ACUTE LIMB ISCHAEMIA
Acute arterial occlusion can be associated with a spec-
trum of presenting signs and symptoms (see
Differential Diagnosis, C 2.1.3, P 5117). At one
extreme, a patient without underlying arterial occlu-
sive disease who suffers an acute embolic occlusion at
the femoral bifurcation may present with a profound-
ly ischaemic lower extremity, necessitating urgent
intervention. In contrast, at the other extreme, an acute
embolic or thrombotic occlusion of a chronically dis-
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eased but only partially patent artery may be associat-
ed with only mild progression of chronic symptoms
and modest deterioration in haemodynamics. The
problems presented by the acutely ischaemic limb are
compounded by inadequate opportunities to treat sig-
nificant comorbidities and by the problems after
revascularisation caused by reperfusion injury.
Therefore, the acutely ischaemic limb can present an
extreme clinical challenge to the clinician. Despite
progress in many areas of vascular reconstruction, ALI
continues to be associated with substantial limb loss
and appreciable mortality, usually attributable to
coexistent cardiac disease (10%-20%).1-2·3.4
C 4.1
Immediate Management of Acute Limb Ischaemia
The treatment of ALI is an emergency situation.
Minimising any delay in relieving the occlusion is
essential, because risk of limb loss increases with the
duration of the acute ischaemia. In one study, the
amputation rates were found to be proportional to the
interval between onset of acute limb ischaemia and
exploration (6% if within 12 hours, 12% within 13 to 24
hours, and 20% after 24 hours). Most older studies
show even higher amputation rates with time. It is
therefore important to eliminate diagnostic measures
that are not essential to the needed intervention and to
immediately make preliminary arrangements for that
treatment, insisting on its priority.
Pre-intervention anticoagulation with therapeutic
levels of heparin reduces morbidity and mortality
(compared with not using anticoagulants) and is part
of the overall treatment strategy for these patientsP It
not only helps prevent clot propagation but, in the
case of arterial embolism, mitigates against another
embolus. Therefore, the immediate emergency man-
agement of all such patients includes heparinisation.
Administration of heparin may be briefly delayed in
cases in which spinal or epidural anaesthesia is impor-
tant for overall patient management. Pain should be
controlled by appropriate analgesia. Oxygen inhala-
tion may be helpful, and there is some experimental
evidence of its benefit," Appropriate treatment for con-
gestive cardiac failure or atrial or ventricular arrhyth-
mias should be initiated. These and other such sup-
portive measures should be commenced immediately
and continued through the intervention, rather than
waiting until after it. Their ultimate importance can-
not be overemphasised.
There is no evidence that vasoactive drugs are help-
ful in ALI. The same can be said for sympathectomy.
Wherever possible, simple measures to improve exist-
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ing perfusion should be undertaken, before or after
revascularisation, or occasionally as an attempt to
avoid surgery in a high-risk patient with marginal via-
bility. These include: keeping the foot dependent,
avoiding extrinsic pressure over the heel or bony
prominence, avoiding temperature extremes (cold
induces vasoconstriction, whereas heat raises the
metabolic rate and circulatory demand), maximising
tissue oxygenation, and correcting hypotension. Used
in combination with measures to maximise cardiac
function, these may produce gratifying results.
In summary, although the ischaemic limb is the nat-
ural focus of attention, the prime consideration should
be life rather than limb. The mentioned supportive
measures should be an integral part of the overall
management of these patients.
Recommendation 55: Anticoagulant therapy in
acute limb ischaemia
Intravenous heparin at full anticoagulant dosage
should be given as soon as the diagnosis of acute
limb ischaemia has been made, provided that
heparin is not contraindicated and that
spinal/epidural anaesthesia is not planned.
Critical Issue 21: Subcutaneous heparin in acute
limb ischaemia
There is a need to resolve whether intravenous
administration of unfractionated heparin before
treatment can be replaced with subcutaneous
un fractionated or low-molecular-weight heparin in
the setting of acute limb ischaemia.
Recommendation 56: Vasoactive drugs or sympa-
thectomy in acute limb ischaemia
There is no evidence that "vasoactive" drugs or
sympathectomy are of benefit in the treatment of
acute limb ischaemia.
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C 4.2




Formal angiography is performed only in patients
in whom the degree of severity allows time (ie,
severity levels I and l1a). In many such patients,
depending on other factors (see Recommendation
57), angiographic findings, catheter-directed throm-
bolytic therapy is the initial treatment chosen. The
choice depends on location and anatomy of lesions,
duration of the occlusion, the type of clot (embolus
vs thrombosis), patient risk (comorbidities), and
risk of procedure (eg, embolectomy under local vs
arterial bypass under general anaesthesia).
Contraindications to thrombolysis must obviously
be observed. However, as a gentler method of clot
removal that potentially may avoid or reduce the
scope of open surgery, catheter-directed thromboly-
sis is often the initial treatment chosen in levels I
and -l1a patients. In such instances, the next step
after performing angiography for acute occlusion is
to pass a guidewire through the occluded artery. If
the guidewire passes, then intrathrombus lysis
should be initiated. If the catheter fails to pass,
regional infusion with the catheter placed proximal-
ly may be considered in an effort to facilitate one
subsequent attempt at catheterising the thrombosed
segment. Regional infusion should not exceed 6
hours before attempting to achieve the optimal
catheter position. Any clinical deterioration during
regional infusion should signal the need to discon-
tinue thrombolysis and proceed with surgical revas-
cularisation.
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